Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Exact Sciences Cor (EXAS)

Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
What's Fueling Tempus AI's Explosive Sales Growth?

Chicago-based Tempus AI, Inc. TEM is experiencing robust revenue growth, marked by record-setting financial performance. In the first quarter of 2025, the company reported a 75.4% year-over-year increase...

AZN : 71.13 (-0.95%)
EXAS : 51.91 (-2.64%)
EXEL : 44.86 (-0.69%)
TEM : 56.88 (-4.56%)
Hologic Climbs 13% in a Month: How Should You Play the Stock?

After lagging for months, Hologic HOLX has picked up momentum in recent weeks. Shares of the Marlborough, MA-based company have climbed 13.3% over the past month, higher than the industry and the broader...

HOLX : 65.72 (-1.69%)
EXAS : 51.91 (-2.64%)
BDX : 175.97 (-0.86%)
2 Brilliant Stocks to Buy With $200 and Hold for 5 Years

EXAS : 51.91 (-2.64%)
TMDX : 112.46 (-9.87%)
Stocks Settle Higher on Trade Optimism and US Labor Market Strength

The S&P 500 Index ($SPX ) (SPY ) Friday closed up +1.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.60%. June E-mini S&P futures...

AMAT : 197.93 (-0.05%)
UAL : 87.69 (-4.34%)
AAPL : 211.16 (-0.59%)
AVGO : 274.38 (-0.37%)
EXAS : 51.91 (-2.64%)
IRM : 97.99 (-0.98%)
BIDU : 86.93 (-1.71%)
TXN : 221.25 (+0.72%)
ABNB : 135.35 (-1.20%)
$IUXX : 22,780.60 (-0.21%)
DUOL : 370.82 (-2.53%)
ZNU25 : 110-230s (-0.45%)
Stocks Supported by Hopes of US-China Trade Talks and a Buoyant US Labor Market

The S&P 500 Index ($SPX ) (SPY ) today is up +1.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.00%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.30%. June E-mini S&P futures (ESM25...

AMAT : 197.93 (-0.05%)
UAL : 87.69 (-4.34%)
AAPL : 211.16 (-0.59%)
AVGO : 274.38 (-0.37%)
EXAS : 51.91 (-2.64%)
IRM : 97.99 (-0.98%)
BIDU : 86.93 (-1.71%)
TXN : 221.25 (+0.72%)
ABNB : 135.35 (-1.20%)
$IUXX : 22,780.60 (-0.21%)
DUOL : 370.82 (-2.53%)
ZNU25 : 110-230s (-0.45%)
Stocks Climb on Possible US-China Trade Talks and a Resilient US Labor Market

The S&P 500 Index ($SPX ) (SPY ) today is up +1.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.15%. June E-mini S&P futures (ESM25...

AMAT : 197.93 (-0.05%)
UAL : 87.69 (-4.34%)
AAPL : 211.16 (-0.59%)
EXAS : 51.91 (-2.64%)
BIDU : 86.93 (-1.71%)
TXN : 221.25 (+0.72%)
ABNB : 135.35 (-1.20%)
$IUXX : 22,780.60 (-0.21%)
DUOL : 370.82 (-2.53%)
ZNU25 : 110-230s (-0.45%)
PDD : 104.91 (-0.06%)
ESU25 : 6,300.00s (-0.38%)
Exact Sciences: Q1 Earnings Snapshot

Exact Sciences: Q1 Earnings Snapshot

EXAS : 51.91 (-2.64%)
2 Reasons to Like EXAS (and 1 Not So Much)

2 Reasons to Like EXAS (and 1 Not So Much)

EXAS : 51.91 (-2.64%)
Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers

NTRA : 160.43 (-1.79%)
EXAS : 51.91 (-2.64%)
INCY : 68.59 (-2.49%)
REGN : 567.74 (+1.43%)
Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)

Reflecting On Immuno-Oncology Stocks’ Q4 Earnings: Regeneron (NASDAQ:REGN)

NTRA : 160.43 (-1.79%)
EXAS : 51.91 (-2.64%)
INCY : 68.59 (-2.49%)
REGN : 567.74 (+1.43%)

Barchart Exclusives

Gold's Bull Run: Seasonal Strength Meets Conflicting COT Report—Are You In?
Gold's all-time high $3,509.9! Central banks bought big, but the COT report waves a red flag. Seasonal gains await—Market players, read or regret! Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar